Fertility platform Zora Health secures $740k funding
Fertility platform Zora Health secures $740k funding
Backed by VC firm Antler, the platform wants to simplify the IVF and egg freezing journey.
Singapore-based fertility platform Zora Health has announced the launch of its fertility platform, after securing $740,000 in funding.
Founder Anna Vanessa Haotanto launched the start-up in May 2023 after experiencing her own health issues. Zora Health has said that it already has a waitlist of more than 180 patients and partnerships with more than 50 clinics in eight countries globally.
The Zora Health platform will match patients with doctors globally and provide expert support. Initial offerings will include egg freezing, IVF, fertility testing and consultation services.
Anna previously told Tatler Asia:
“The global fertility market, estimated at US$54 billion (S$73 billion) is significantly underserved. This high-growth segment faces minimal competition in Southeast Asia, with only three fertility tech companies operating in hardware or direct-to-consumer e-commerce.”
Central to the idea behind Zora Health is that it will eventually be an ecosystem of integrated support - virtual and in-person consultations, medical concierge services, fertility education workshops for corporations and fertility financing.
Announcing this funding round, Anna said:
“The fertility treatment landscape is daunting to the women and couples seeking fertility care due to the multitude of service options and providers, complicated regulations and confusing pricing structures. Zora Health’s integrated approach addresses these issues head-on, simplifying the process for patients, healthcare providers and corporations in a fragmented market.”
Funding for this round was from VC firm Antler, and includes a group of angel investors. Zora Health has said that 55 per cent of its investor lineup consists of women.
Zora Health has said that it already has a waitlist of more than 180 patients and partnerships with more than 50 clinics in 16 cities in eight countries globally.
Within Singapore, there is growing interest in egg freezing after rules were relaxed in July 2023 allowing women between 21 - 37 years old to undergo elective egg freezing.